Skip to main content
    G

    Genenta Science SpA ADR (GNTA)

    Official site

    INDUSTRIALS • BIOTECHNOLOGY • NASDAQ

    $0.66
    -0.06 (-8.56%)

    Market Cap: $34.81M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    100%(3/3)
    Avg Surprise
    +10.97%
    Streak
    3 Q
    PeriodReportedEst.SurpriseB/MYoY
    Dec 25
    Reported Mar 31
    		$-0.36$-0.36+0.00%Beat-23.4%
    Sep 25
    Reported Oct 10
    		$-0.20$0.00N/AMiss+50.1%
    Dec 24
    Reported Mar 28
    		$-0.27$0.00N/AMiss+28.3%
    Jun 24
    Reported Jun 30
    		$-0.24N/AN/ABeat-96.1%
    Dec 23
    Reported Apr 24
    		$-0.29$-0.42+29.66%Beat-81.5%
    Jun 23
    Reported Jun 30
    		$-0.40$-0.41+3.25%Beat-149.7%
    Dec 22
    Reported Apr 26
    		$-0.38N/AN/ABeat-190.2%
    Jun 22
    Reported Oct 7
    		$-0.12$0.00N/ABeat+2.6%
    Mar 21
    Reported Jun 30
    		$-0.16$0.00N/AMiss-68.2%
    Dec 20
    Reported Mar 31
    		$-0.16$0.00N/AMiss-69.6%
    Sep 20
    Reported Dec 31
    		$-0.13$0.00N/AMiss+10.2%
    Jun 20
    Reported Sep 30
    		$-0.12$0.00N/AMiss-
    Mar 20
    Reported Jun 29
    		$-0.10$0.00N/AMiss-
    Dec 19
    Reported Mar 31
    		$-0.09$0.00N/AMiss-
    Jun 19
    Reported Jun 30
    		$-0.14N/AN/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-38.00%ROICN/A
    Financial Health
    Debt/Equity0.35xInterest CoverageN/A
    Current Ratio14.16xQuick Ratio14.16x
    Trading Statistics
    Beta0.76Avg Volume62.37K
    52-Week High$6.2052-Week Low$0.55

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.75
    SMA 20$0.72
    SMA 50$0.94
    SMA 200$1.09
    EMA 10$0.73
    EMA 20$0.76
    EMA 50$0.92
    EMA 200$1.34

    MACD

    Line: -0.06Signal: -0.07Hist: 0.02

    ADX

    ADX: 34.2+DI: 13.9-DI: 24.0

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down40.0
    PSAR$0.85

    Bollinger Bands

    Upper Band$0.81
    Lower Band$0.63
    %B Position2430%(Upper)
    Band Width0.16

    RSI (14-Day)

    Neutral
    37.0

    Momentum Oscillators

    Stoch %K33.1
    Stoch %D47.7
    Williams %R-95.4
    ROC (10d)-5.7%
    Momentum-0.04
    CCI (20d)-81.8
    MFI (14d)47.5

    Volatility Measures

    ATR (14d)$0.08(11.8%)
    StdDev (20d)0.04
    Hist Vol100.6%(High)

    Volume Flow

    VWAP$0.69
    OBV162.7M
    AD Line-42.5M
    CMF (20d)-0.259

    Volume Metrics

    Avg Vol (20d)62.1K
    Vol Ratio1.4x
    VWMA (20d)$0.71

    Pivot Points

    R3$0.77
    R2$0.76
    R1$0.74
    Pivot Point$0.73
    S1$0.71
    S2$0.70
    S3$0.68

    Advanced Oscillators

    TSI-22.21
    Ultimate Osc34.9
    KST-188.90

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Dec 2024Jun 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022
    Total RevenueN/A$0N/A$0N/AN/AN/AN/AN/AN/AN/AN/A
    Cost of Revenue$14,035$14,035$12,996$12,996$23,406$22,289$20,947N/A$20,947N/AN/AN/A
    Gross Profit$-14,035$-14,035$-12,996$-12,996$-23,406$-22,289$-20,947N/A$-20,947N/AN/AN/A
    Operating Expenses$3.18M$3.18MN/A$3.14M$5.46M$4.53M$4.83MN/A$6.72M$6.89MN/A$4.15M
    R&D$1.24M$1.24M$1.36M$1.36M$2.90M$0$2.51M$0$3.89M$3.70M$0$1.64M
    SG&A$0$1.95M$1.93M$1.78M$2.47M$2.48M$2.38M$0$1.44M$3.19M$0$2.51M
    Operating Income$-3,196,807$-3,196,807$-3,154,018$-3,154,018$-5,483,981$-4,550,642$-4,848,906N/A$-6,737,460$-6,889,855N/A$-4,154,137
    Interest Income$0$463,451$0$504,927$0$0$0$0$0$0$0$0
    Interest Expense$8,933$8,933$364,524$364,524$244,931$0$0$0$0$0$0$0
    Income Before Tax$-2,683,232$-2,683,232$-3,567,481$-3,567,481$-5,095,151$-4,067,353$-4,803,160$0$0$-6,365,442$0$-2,112,321
    Income Tax Expense$0$0$0$0$0$0$-1$0$3,000$0$0$0
    Net Income$-2,683,232$-2,683,232$-3,567,481$-3,567,481$-5,095,151$-4,067,353$-4,803,160N/AN/A$-6,365,442N/A$-2,112,321
    EBITDA$-2,660,264$-2,660,264$-3,189,096$-3,189,961$-5,073,049$-4,045,095$-4,782,213N/AN/A$-6,362,116N/A$-2,109,509
    EBIT$-2,674,299$-2,674,299$-3,202,957$-3,202,957$-5,095,151$-4,067,353$-4,803,160N/AN/A$-6,365,442N/A$-2,112,321
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about GNTA

    News

    [6-K] Genenta Science S.p.A. Current Report (Foreign Issuer) | GNTA SEC Filing - Form 6-K

    Genenta Science S.p.A. announced that the Court of Milan denied an application by minority shareholders seeking to suspend a capital increase approved on May 18, 2026...

    Stock Titan•10/7/26•Neutral

    At $1.30 a share, Fin Posillipo buys depositary shares in Genenta Science (Nasdaq: GNTA).

    Fin Posillipo S.p.A. acquired 110,000 American Depository Shares (ADS) in Genenta Science (GNTA) at $1.30 per ADS, totaling approximately $143,000...

    Stock Titan•10/2/26•Neutral

    Sòphia High Tech Flight Hardware on Board VEGA-C VV30 as the European Launcher Carries Sentinel-3C and FLEX into Orbit

    Genenta Science S.p.A. announced that its strategic investment, Sòphia High Tech S.r.l., contributed flight hardware to the VEGA-C VV30 mission. Sòphia HT manufactures the Spring Assembly...

    Yahoo Finance Singapore•9/15/26•Bullish

    Genenta Science (NASDAQ: GNTA) Transitions Strategy Following Full Acquisition of A.T.C.

    Genenta Science (NASDAQ: GNTA) has fully acquired A.T.C. S.r.l., marking a strategic pivot from a biotechnology company to an industrial consolidator. This shift involves securing majority or full stakes in Italian firms...

    Kalkine Media•9/2/26•Bullish

    Enterprise value to EBITDA forward of Genenta Science SpA Sponsored ADR – MUN:K5F

    This article provides financial data for Genenta Science SpA Sponsored ADR (MUN:K5F) on TradingView, specifically focusing on its enterprise value to EBITDA forward. It indicates that the market was closed with no trades...

    TradingView•8/8/26•Neutral

    GNTA Valuation and Fair Value

    P/B
    0.6x
    See GNG's fair value

    GNTA Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -38.0%

    GNTA Competitors

    CompanyTicker
    Mural Oncology plcMURA
    CervoMed Inc.CRVO
    Lite Strategy, Inc.LITS
    CryoCell International IncCCEL
    Edesa Biotech IncEDSA
    NanoViricides IncNNVC
    Generation Bio CoGBIO
    Elutia Inc.ELUT

    Sector: Healthcare

    GNTA Bull Case vs Bear Case

    Bear case

    • GNTA beat EPS estimates in 25.0% of its last 8 reported quarters.

    GNTA Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    11.0%

    Frequently Asked Questions About GNTA

    Does GNTA pay dividends?

    Genenta Science SpA ADR (GNTA) does not currently pay a regular dividend.

    What is GNTA's market cap?

    Genenta Science SpA ADR (GNTA) has a market capitalization of $34.81M with a current stock price of $0.66.

    Related stocks

    Sector: Healthcare

    All stocks starting with G

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In